Benzodeazaoxaflavins as Sirtuin Inhibitors with Antiproliferative Properties in Cancer Stem Cells
Journal of Medicinal Chemistry2012Vol. 55(18), pp. 8193–8197
Citations Over TimeTop 20% of 2012 papers
Dante Rotili, Domenico Tarantino, Vincenzo Carafa, Chantal Paolini, Jörg Schemies, Manfred Jung, Giorgia Botta, Salvatore Di Maro, Ettore Novellino, Christian Steinkühler, Ruggero De Maria, Paola Gallinari, Lucia Altucci, Antonello Mai
Abstract
Inhibition of sirtuins has recently been proposed as a promising anticancer strategy. Some of the new benzodeazaoxaflavins (2a, 2b, and 2d) here reported as SIRT1/2 inhibitors were endowed with pro-apoptotic properties in human U937 leukemia cells and, most importantly, together with the prototype MC2141 (1) displayed antiproliferative effects in cancer stem cells from patients with colorectal carcinoma and glioblastoma multiforme, known to be highly tumorigenic, resistant to conventional cancer chemotherapy, and responsible, at least in part, for cancer relapse or recurrence.
Related Papers
- → Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2(2012)63 cited
- → Zebrafish as a Model Organism to Evaluate Drugs Potentially Able to Modulate Sirtuin Expression(2011)31 cited
- → Virtual screening approach of sirtuin inhibitors results in two new scaffolds(2015)20 cited
- → Mechanism-based affinity capture of sirtuins(2010)25 cited
- → Sirtuins as Potential Drug Targets for Metabolic Diseases(2011)